Skip to content
MCK McKesson Corp NYSE
381.64 USD -1.00% -3.87
OPEN 386.00
DAY RANGE 387.94 - 380.47
52 WEEK RANGE 401.78 - 219.23
Interactive Brokers Logotype

Buy MCK stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 54.2B
Enterprise value 59.1B
Trailing pe 27.027563
Forward pe 14.508346
Peg ratio 1.49
Price to sales ttm 0.19934534
Enterprise to revenue 0.217
Enterprise to ebitda 15.55


Fiscal year ends 2022-03-31
Most recent quarter 2022-09-30
Profit margin 0.0075499997
Operating margin 0.01203
Return on assets ttm 0.03229
Income statement
Revenue ttm 272B
Revenue per share ttm 1855.573
Quarterly revenue growth 0.054
Gross profit ttm 13.1B
Ebitda 4.1B
Net income to common ttm 2.1B
Diluted eps ttm 14.15
Quarterly earnings growth yoy 2.468
Balance sheet
Revenue ttm 272B
Total cash mrq 2.9B
Total cash per share mrq 20.565
Total debt mrq 7.3B
Current ratio mrq 0.961
Book value per share mrq -12.462
Cash flow
Operating cash flow ttm 4.4B
Levered free cash flow ttm 3.7B

Stock statistics

Shares outstanding 141.8M
Float shares 138.4M
Avg 10 volume 1M
Avg 30 volume 1.2M
Shares short 2.5M
Short ratio 2.1
Short percent of shares outstanding 0.0197
Percent held by insiders 0.0010899999
Percent held by institutions 0.89155

Stock price summary

Fifty two week low 219.23
Fifty two week high 401.78
Fifty two week change 38.924
Beta 0.632183
Day 50 ma 367.7884
Day 200 ma 334.91934

Dividends and splits

Forward annual dividend rate 2.16
Forward annual dividend yield 0.0056
Trailing annual dividend rate 1.95
Trailing annual dividend yield 0.0050407136
5 year average dividend yield 0.95
Payout ratio 0.1378
Dividend date 2023-01-03
Ex dividend date 2022-11-30
Last split factor 2-for-1 split
Last split date 1998-01-05

McKesson (MCK) company profile

McKesson Corp. (NYSE: MCK) is a healthcare supply chain management company offering retail pharmacy, community oncology and speciality care, and healthcare information solutions. The company covers the United States and the global market operating through the segments of U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions. The firm also provides distribution and services to wholesale, institutional, and retail customers in several European countries and Canada.